Motus Nova

Motus Nova designs and manufactures FDA Class I cleared robotic exoskeletons for at-home neurological rehabilitation, specializing in stroke recovery and brain injury recovery. The company's flagship products—Motus Hand and Motus Foot—are active-assist robotic devices that deliver clinic-quality therapy in patient homes. These pneumatic-driven systems provide high-dose, gamified rehabilitation using constraint-induced movement therapy and interactive games to enhance motor function, strength, and fine motor control. Available via subscription model (typically $10/hour of use), the devices are covered by most major insurances including Medicare. Motus systems include integrated touchscreen monitoring, real-time progress tracking, clinical support, and personalized therapy protocols. Since 2020, over 3,000 home units have been deployed across all 50 states, with approximately 200 additional devices in clinical settings. Clinical trials at Emory and VA hospitals demonstrated equivalent outcomes between robotic and therapist-delivered therapy, with 82% of users reporting functional improvements within months.